The content is available as a PDF (823.1 KB).
editorial . 2020 Apr 30:glaa104. doi: 10.1093/gerona/glaa104
COVID-19 Pandemic: Considerations for Safe Medication Use in Older Adults with Multimorbidity and Polypharmacy
Nagham J Ailabouni
1,✉, Sarah N Hilmer
2, Lisa Kalisch
1, Rhiannon Braund
3, Emily Reeve
1,4
Nagham J Ailabouni, BPharm, PhD
1
University of South Australia, Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, Adelaide, Australia
Find articles by Nagham J Ailabouni
Sarah N Hilmer, BScMed(Hons), MBBS(Hons), PhD, FRACP
2
Kolling Institute of Medical Research, Royal North Shore Hospital and Northern Clinical School, Faculty of Medicine and Health, University of Sydney, St Leonards, New South Wales, Australia
Find articles by Sarah N Hilmer
Lisa Kalisch, BPharm, PhD
1
University of South Australia, Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, Adelaide, Australia
Find articles by Lisa Kalisch
Rhiannon Braund, BSc, BPharm, PhD
3
University of Otago, New Zealand Pharmacovigilance Centre, Department of Preventive and Social Medicine, Dunedin, New Zealand
Find articles by Rhiannon Braund
Emily Reeve, BPharm(Hons), PhD
1
University of South Australia, Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, Adelaide, Australia
4
Geriatric Medicine Research, Faculty of Medicine, and College of Pharmacy, Dalhousie University and Nova Scotia Health Authority, Halifax, Canada
Find articles by Emily Reeve
1
University of South Australia, Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, Adelaide, Australia
2
Kolling Institute of Medical Research, Royal North Shore Hospital and Northern Clinical School, Faculty of Medicine and Health, University of Sydney, St Leonards, New South Wales, Australia
3
University of Otago, New Zealand Pharmacovigilance Centre, Department of Preventive and Social Medicine, Dunedin, New Zealand
4
Geriatric Medicine Research, Faculty of Medicine, and College of Pharmacy, Dalhousie University and Nova Scotia Health Authority, Halifax, Canada
✉
Corresponding Author: Dr Nagham J Ailabouni, Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Nagham.ailabouni@unisa.edu.au
Received 2020 Apr 3.
© The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7197623 PMID: 32353109